Most Recent
The Australian Competition and Consumer Commission has taken swift action to allow medical technology companies to coordinate on supplying ventilators, protective gear and other equipment in high demand due to the coronavirus.
Group members in two settled class actions against clothing retailer Surfstitch have been told the settlement amount available to them has plummeted amid a "very difficult retail environment".
The Australian Competition and Consumer Commission has approved Coles' planned acquisition of chilled meals supplier Jewel, saying the sale was better for competition than the liquidation of Jewel's assets.
The judge overseeing the trial in a trade secrets case brought by Australian auto electronics developer Directed Electronics OE against its rivals is considering how the cross-examination of witnesses will proceed given current restrictions imposed on gatherings due to the coronavirus, including in the event of a possible lockdown.
A hearing has been vacated in ACCC proceedings brought against Sony alleging it misled gamers who purchased faulty PlayStation games, with any penalty the entertainment company should face to be decided by the court on written submissions alone as it seeks to avoid in-person hearings.
Construction giant Boral is facing a shareholder class action for allegedly failing to disclose financial irregularities in its US windows business.
The Australian Competition and Consumer Commission has given the go-ahead for supermarkets to work together immediately to ensure consumers have access to fresh food and groceries, after a wave of panic buying lead to product shortages and delivery disruptions across the country.
A judge has signed off on a $42.5 million settlement of a class action against Cash Converters, brought on behalf of consumers that look out personal loans, in a move that will see the plaintiffs firm behind the case pocket $12.4 million.
The Kingdom of Spain is keeping up its fight against the enforcement of two arbitration awards putting it on the hook for paying two investment companies $375 million.
Generic drug maker Juno Pharmaceuticals has agreed to stopped planned sales of its cheap version of Millennium Pharmaceuticals anti-cancer medication Velcade in Australia as part of a settlement of its lawsuit alleging two patents covering the drug were invalid.